Your browser doesn't support javascript.
loading
Predictors of Mortality Among a National Cohort of Veterans With Recurrent Clostridium difficile Infection.
Appaneal, Haley J; Caffrey, Aisling R; Beganovic, Maya; Avramovic, Sanja; LaPlante, Kerry L.
Afiliação
  • Appaneal HJ; Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, Rhode Island.
  • Caffrey AR; College of Pharmacy, University of Rhode Island, Kingston, Rhode Island.
  • Beganovic M; Center of Innovation in Long-Term Support Services, Providence Veterans Affairs Medical Center, Providence, Rhode Island.
  • Avramovic S; Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, Rhode Island.
  • LaPlante KL; College of Pharmacy, University of Rhode Island, Kingston, Rhode Island.
Open Forum Infect Dis ; 5(8): ofy175, 2018 Aug.
Article em En | MEDLINE | ID: mdl-30327788
BACKGROUND: Though recurrent Clostridium difficile infection (CDI) is common and poses a major clinical concern, data are lacking regarding mortality among patients who survive their initial CDI and have subsequent recurrences. Risk factors for mortality in patients with recurrent CDI are largely unknown. METHODS: Veterans Affairs patients with a first CDI (stool sample with positive C. difficile toxin(s) and ≥2 days CDI treatment) were included (2010-2014). Subsequent recurrences were defined as additional CDI episodes ≥14 days after the stool test date and within 30 days of the end of treatment. A matched (1:4) case-control analysis was conducted using multivariable conditional logistic regression to identify predictors of all-cause mortality within 30 days of the first recurrence. RESULTS: Crude 30-day all-cause mortality rates were 10.6% for the initial CDI episode, 8.3% for the first recurrence, 4.2% for the second recurrence, and 5.9% for the third recurrence. Among 110 cases and 440 controls, 6 predictors of mortality were identified: use of proton pump inhibitors (PPIs; odds ratio [OR], 3.86; 95% confidence interval [CI], 2.14-6.96), any antibiotic (OR, 3.33; 95% CI, 1.79-6.17), respiratory failure (OR, 8.26; 95% CI, 1.71-39.92), congitive dysfunction (OR, 2.41; 95% CI, 1.02-5.72), nutrition deficiency (OR, 2.91; 95% CI, 1.37-6.21), and age (OR, 1.04; 95% CI, 1.01-1.07). CONCLUSIONS: In our national cohort of Veterans, crude mortality decreased by 44% from the initial episode to the third recurrence. Treatment with antibiotics, use of PPIs, and underlying comorbidities were important predictors of mortality in recurrent CDI. Our study assists health care providers in identifying patients at high risk of death after CDI recurrence.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2018 Tipo de documento: Article